Sedative, hypnotic or anxiolytic dependence with unspecified sedative, hypnotic or anxiolytic-induced disorder
ICD-10 F13.29 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic dependence with unspecified sedative, hypnotic or anxiolytic-induced disorder.
F13.29 refers to a condition characterized by a dependence on sedative, hypnotic, or anxiolytic substances, which can lead to significant impairment or distress. This code is used when the specific substance causing the dependence is not specified. Patients may experience withdrawal symptoms when not using the substance, and they may engage in compulsive use despite negative consequences. The disorder can manifest as tolerance, where higher doses are needed to achieve the same effect, and withdrawal symptoms can include anxiety, insomnia, and seizures. Treatment often involves a combination of behavioral therapies and medication management to address both the dependence and any co-occurring mental health disorders. It is crucial for healthcare providers to document the patient's history, substance use patterns, and any treatment interventions to ensure accurate coding and appropriate care.
Comprehensive substance use history, including duration and quantity of use, withdrawal symptoms, and treatment response.
Patients presenting with withdrawal symptoms, seeking detoxification, or requiring long-term management of dependence.
Consideration of co-occurring mental health disorders and the need for integrated treatment approaches.
Detailed psychiatric evaluation, including mental status examination and assessment of substance use impact on mental health.
Patients with anxiety disorders using anxiolytics, presenting with exacerbated symptoms during withdrawal.
Need for careful monitoring of psychiatric symptoms during treatment and potential medication adjustments.
When a patient with sedative dependence also seeks help for smoking cessation.
Document the patient's substance use history and counseling provided.
Addiction specialists may need to coordinate care with tobacco cessation programs.
F13.29 indicates dependence with unspecified sedative, hypnotic, or anxiolytic-induced disorder, while F13.20 refers to uncomplicated dependence without withdrawal symptoms.
